Abstract OBJECTIVE: To evaluate the roles of plasma mast cell carboxypeptidase and chymase in the diagnosis of allergic diseases by measuring the contents of both in children. METHODS: A total of 59 children with allergic diseases and 53 healthy children were recruited into the study. Plasma levels of mast cell carboxypeptidase and chymase were measured using ELISA. RESULTS: The plasma levels of mast cell carboxypeptidase and chymase in children with allergic children were 1.089±0.752 ng/mL and 0.905(0.375-2.318) ng/mL, respectively, which were significantly higher than those in healthy children ［0.593±0.380 ng/mL and 0.454 (0.097-1.077) ng/mL respectively; P<0.05］.There was a significantly positive correlation between plasma mast cell carboxypeptidase and chymase levels in children with allergic diseases (r=0.684, P<0.01). CONCLUSIONS: Plasma levels of mast cell carboxypeptidase and chymase increase in children with allergic diseases, suggesting that mast cell carboxypeptidase and chymase may serve as the indexes for the diagnosis of allergic diseases.
PAN Qiong,DING Mei-Fang,ZHANG Shu et al. Measurement of plasma mast cell carboxypeptidase and chymase levels in children with allergic diseases[J]. 中国当代儿科杂志, 2011, 13(10): 814-816.
PAN Qiong,DING Mei-Fang,ZHANG Shu et al. Measurement of plasma mast cell carboxypeptidase and chymase levels in children with allergic diseases[J]. CJCP, 2011, 13(10): 814-816.
［1］Matasar MJ, Neugut AI. Epidemiology of anaphylaxis in the United States［J］. Curr Allergy Asthma Rep, 2003, 3(1): 30-35.
［2］Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006［J］. J Allergy Clin Immunol, 2007, 119(4): 1018-1019.
［3］Hamilton RG. Laboratory analyses in the diagnosis of human allergic disease［J］. Methods, 1997, 13(1): 25-32.
［4］Baur X, Szuppon A. Diagnostic validation of specific IgE antibody concentrations, skin prock testing, and challenge tests in chemical workers with symptoms of sensitivity different anhy-drides［J］. Allergy Clin Immunol, 1995, 96(4): 489-494.
［5］Hamelmann E, Tadeda K, Oshiba A, Gelfand EW. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness: A murine model［J］．Allergy, 1999, 54(4): 297-305.
［6］Geha RS. Regulation of IgE synthesis in human［J］. J Allergy Clin Immunol, 1992, 90(2): 143-150.
［7］Sala A, Guilarte M, Zhou X, Labrador M, Luengo O, Rueda M, et al. Mast cell tryptase in anaphylaxis diagnosis. Is it sufficient?［J］. Allergy, 2008,63(Suppl 88): 567.
［8］Zhou X, Buckley MG, Lau LC, Summers C, Pumphrey RSH, Walls AF. Mast cell carboxypeptidase as a new clinical marker for anaphylaxis［J］. J Allergy Clin Immunol, 2006, 117(Suppl 2): S85.
［9］Brown TA, Whitworth HS, Zhou XY, Lau L, Eren E, Walls AF. Mast cell carboxypeptidase as a confirmatory and predictive marker in allergic reactions to drugs［J］. J Allergy Clin Immunol, 2011, 127(2): 143-144.
［10］Alangari A, Lau LC, Zhou XY, Mochizuki A, Salagean EM, Salib RJ, et al. Differential release and clearance of mast cell and basophil mediators in the upper airways of patients with allergic rhinitis［J］. J Allergy Clin Immunol, 2008, 121(Suppl 2): S152.
［11］Zhou X, Cox C, Rajenthirar S, Mahrous A, Masters B, Roche W, et al. Mast cell chymase can disrupt the human bronchial epithelium and stimulate the loss of adhesion molecules［J］. J Allergy Clin Immunol, 2008, 121(Suppl 2): S110.
［12］Sanz ML, Gamboa PM, García-Figueroa BE, Ferrer M. In vitro diagnosis of anaphylaxis［J］. Chem Immunol Allergy, 2010, 95: 125-140.
［14］Jensen EJ, Pedersen B, Schmidt E, Dahl R. Serum IgE in nonatopic smokers and nonsmokers, and recent exsmokers: relation to lung function, airway symptoms, and atopic predisposition［J］. J Allergy Clin Immunol, 1992, 90(2): 224-229.
［16］Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents［J］. N Engl J Med, 1992, 327(6): 380-384.
［17］Sampson HA, Jolie PL. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis［J］. J Allergy Clin Immunol, 1984, 311(6): 372-376.
［19］Nishio H, Takai S, Miyazaki M, Horiuchi H, Osawa M, Uemura K, et al. Usefullness of serum mast cell-spedific chymase levels for postmortem diganosis of anaphylaxis［J］. Int J Legal Med, 2005, 119(6): 331-334.
［20］Feyerabend TB, Hausser H, Tietz A, Blum C, Hellman L, Straus AH, et al. Loss of histochemical identity in mast cells lacking Carboxypeptidase A［J］.Mol Cell Biol, 2005, 25(14): 6199-6210.
